Sorafenib in patients with metastatic renal cell carcinoma refractory to ... - UroToday PDF Print
UroTodayBevacizumab and sunitinib are standard initial therapy in metastatic renal cell carcinoma (mRCC). Despite common use, the safety and activity of sorafenib

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.